Ways to help
About us
Contact Us
Feb 2017
Trish Foundation contributes to first-ever discovery
Jun 2017
Researchers funded by the Trish Foundation making great progress
Dec 2017
Announcement by NHMRC
Jan 2018
2018 Round of Funding Four new Projects announced
Jun 2018
Exciting regrowth of nerve fibres
Jun 2018
Dr Merson secures $1 million from NHMRC
Jun 2018
Findings submitted for publication
Jan 2019
New Research Projects commencing 2019 announced

Vitamin D MS Prevention Trial
Continues to Enrol

The Trish MS Research Foundation is helping to fund a world-first clinical trial of vitamin D to test whether it may be able to help prevent MS. Over the last decade the evidence that low levels of vitamin D are associated with an increased risk of developing MS has been mounting.

However, if vitamin D supplementation is to be adopted as an early, preventative intervention for people at high risk of developing MS, rigorous evidence for optimum dosage, efficacy and safety is required from a carefully designed randomised controlled trial.

Australian expertise in this area has made Australia and New Zealand a pivotal location to conduct this trial. MS Research Australia are coordinating the trial, with a consortium of highly experienced MS neurologists, triallists, endocrinologists and epidemiologists.

20 sites in MS clinics around Australia and New Zealand are continuing to enroll people who have experienced their first episode suggestive of MS.

Participants will take a daily oral dose of one of three doses of vitamin D or placebo for one year. The trial is progressing steadily and results are expected in 2017.

For more information visit

Trish Foundation & MS Research Australia Working together to find a cure for MS
Copyright © Trish Multiple Sclerosis Research Foundation. All rights reserved.